Trifasciatine B - Compound Card

Trifasciatine B

Select a section from the left sidebar

Trifasciatine B

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Flavonoid
    • Subclass: Flavone
Canonical Smiles c1(ccc2c(c1OC)OC[C@@](C2=O)(Cc1cc2c(cc1)OCO2)O)C
InChI InChI=1S/C19H18O6/c1-11-3-5-13-17(16(11)22-2)23-9-19(21,18(13)20)8-12-4-6-14-15(7-12)25-10-24-14/h3-7,21H,8-10H2,1-2H3/t19-/m1/s1
InChIKey CVIORMBYBSBVQO-LJQANCHMSA-N
Formula C19H18O6
HBA 6
HBD 1
MW 342.35
Rotatable Bonds 3
TPSA 74.22
LogP 2.28
Number Rings 4
Number Aromatic Rings 2
Heavy Atom Count 25
Formal Charge 0
Fraction CSP3 0.32
Exact Mass 342.11
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Tchegnitegni B, Teponno R, et al. (2015). Sappanin-type homoisoflavonoids from Sansevieria trifasciata Prain. Phytochemistry Letters, 2015, 12, 262-266. [View]
Pubchem: 132580504

No compound-protein relationship available.

Structure

SMILES: O1COc(c12)ccc(c2)CC(C3=O)COc(c34)cccc4

Level: 1

Mol. Weight: 342.35 g/mol

Structure

SMILES: c1cccc(c12)OCCC2=O

Level: 0

Mol. Weight: 342.35 g/mol

Structure

SMILES: O1COc(c12)cccc2

Level: 0

Mol. Weight: 342.35 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.76
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.59
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.44

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.36
Plasma Protein Binding
83.86
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.97
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.71
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.61
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
5.59
Micronucleos
Toxic
NR-AhR
Toxic
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-1.15
Rat (Acute)
2.13
Rat (Chronic Oral)
1.61
Fathead Minnow
4.57
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
409.17
Hydration Free Energy
-7.31
Log(D) at pH=7.4
2.76
Log(P)
3.22
Log S
-3.57
Log(Vapor Pressure)
-7.64
Melting Point
138.07
pKa Acid
8.23
pKa Basic
1.2

No predicted protein targets found for this compound.

Download SDF